Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
Sponsor: Affiliated Hospital of Jiangnan University
Summary
micro-PET imaging showed that 18F-PSMA-1007 had similar or even better pharmacokinetics and imaging performance than 18F-DCFPyL. Due to the convenience of synthesis and good imaging performance, 18F-PSMA-1007 is expected to be popularized in clinical practice.The purpose of this study is to evaluate the performance of 18F-PSMA-1007 in diagnosis, differential diagnosis and efficacy monitoring of prostate cancer.
Key Details
Gender
MALE
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-01-25
Completion Date
2026-12-31
Last Updated
2025-01-24
Healthy Volunteers
No
Conditions
Interventions
18F-PSMA-1007
18F-PSMA-1007 is administered through a superficial dorsal vein, and the patient is given a dose of about 0.1-0.15mCi/kg
18F-FDG
18F-FDG is administered through a superficial dorsal vein, and the patient is given a dose of about 0.1-0.15mCi/kg
Locations (1)
Affiated Hospital of Jiangnan University
Wuxi, Jiangsu, China